» Articles » PMID: 29867980

Semaphorin-3E Produced by Immature Dendritic Cells Regulates Activated Natural Killer Cells Migration

Overview
Journal Front Immunol
Date 2018 Jun 6
PMID 29867980
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Natural killer (NK) cells and dendritic cells (DCs) are two innate immune cells that are critical in regulating innate and adaptive immunity. Cellular functions and migratory responses of NK or DC can be further regulated in NK-DC crosstalk that involves multiple cytokine signals and/or direct cell-cell contacts. Semaphorin-3E (Sema-3E) is a member of a large family of Semaphorin proteins that play diverse regulatory functions in different biological systems upon its binding to the cognate receptors. However, possible role(s) of Sema-3E on the regulation of NK-cell functions has not been elucidated. Here, we first demonstrated that DC and NK cells expressed Sema-3E and its receptors, respectively. To formally address the importance of DC-derived Sema-3E in regulating NK-cell migration, we compared migratory responses of activated NK cells (aNKs) toward different conditioned media of DCs (immature, lipopolysaccharide- or Poly I:C-stimulated) derived from Sema-3E or Sema-3E mice. We observed that aNKs exhibited enhanced migrations toward the conditioned medium of the immature Sema-3E DC, when compared with that of the immature Sema-3E DC. Addition of exogenous recombinant Sema-3E to the conditioned medium of the Sema-3E immature DC (iDC) abrogated such enhanced NK-cell migration. Our current work revealed a novel role of Sema-3E in limiting NK-cell migrations toward iDC in NK-DC crosstalk.

Citing Articles

NK/DC crosstalk-modulating antitumor activity via Sema3E/PlexinD1 axis for enhanced cancer immunotherapy.

Ali A, Alamri A, Hajar A Immunol Res. 2024; 72(6):1217-1228.

PMID: 39235526 DOI: 10.1007/s12026-024-09536-y.


CD11c+ dendritic cells PlexinD1 deficiency exacerbates airway hyperresponsiveness, IgE and mucus production in a mouse model of allergic asthma.

Shan L, Matloubi M, Okwor I, Kung S, Almiski M, Basu S PLoS One. 2024; 19(8):e0309868.

PMID: 39213301 PMC: 11364237. DOI: 10.1371/journal.pone.0309868.


Targeting the chromatin structural changes of antitumor immunity.

Li N, Lun D, Gong N, Meng G, Du X, Wang H J Pharm Anal. 2024; 14(4):100905.

PMID: 38665224 PMC: 11043877. DOI: 10.1016/j.jpha.2023.11.012.


Semaphorins in immune cell function, inflammatory and infectious diseases.

Thomas R, Yang X Curr Res Immunol. 2023; 4:100060.

PMID: 37645659 PMC: 10461194. DOI: 10.1016/j.crimmu.2023.100060.


The relation of the frequency and functional molecules expression on plasmacytoid dendritic cells to postpartum hepatitis in women with HBeAg-positive chronic hepatitis B virus infection.

Wang F, Song M, Hu Y, Yang L, Bi X, Lin Y Front Immunol. 2022; 13:1062123.

PMID: 36439153 PMC: 9681894. DOI: 10.3389/fimmu.2022.1062123.


References
1.
Fernandez N, Lozier A, Flament C, Ricciardi-Castagnoli P, Bellet D, Suter M . Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nat Med. 1999; 5(4):405-11. DOI: 10.1038/7403. View

2.
Kumanogoh A, Kikutani H . Immunological functions of the neuropilins and plexins as receptors for semaphorins. Nat Rev Immunol. 2013; 13(11):802-14. DOI: 10.1038/nri3545. View

3.
Sharma A, Verhaagen J, Harvey A . Receptor complexes for each of the Class 3 Semaphorins. Front Cell Neurosci. 2012; 6:28. PMC: 3389612. DOI: 10.3389/fncel.2012.00028. View

4.
Smyth M, Cretney E, Takeda K, Wiltrout R, Sedger L, Kayagaki N . Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis. J Exp Med. 2001; 193(6):661-70. PMC: 2193421. DOI: 10.1084/jem.193.6.661. View

5.
Semino C, Angelini G, Poggi A, Rubartelli A . NK/iDC interaction results in IL-18 secretion by DCs at the synaptic cleft followed by NK cell activation and release of the DC maturation factor HMGB1. Blood. 2005; 106(2):609-16. DOI: 10.1182/blood-2004-10-3906. View